IBD patients have been found to have a higher risk of lymphoma.

Published Date: 26 Apr 2023

According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.

Read Full News

Latest News

Sacral Fracture Risk After Short-Course RT for Rectal Cancer

A recent retrospective analysis assesses the incidence and risk factors for sacral fractures among patients receiving short-course radiation therapy for rectal cancer.

Heavy Drinking Tied to Young-Onset Pancreatic Cancer

A nationwide Korean cohort study of more than 6.2 million young adults found an association between heavy alcohol use and pancreatic cancer risk before age 50.

How Gut Bacteria Could Trigger Memory Loss as We Age

Researchers found potential links between gut bacteria and memory loss, with gut-brain connections triggering loss of memory encoding in the hippocampus.

AstraZeneca's Liver Cancer Therapy Combo Slows Disease Progression in Late-stage Trial

AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant improvement in ⁠how long patients with a common liver cancer lived...

Symptom-Based H pylori Testing Does Not Prevent Cancer

Most gastric cancers found in people diagnosed with H pylori may already be present at diagnosis, and treatment of the infection may not provide short-term protection.

Evidence Suggest Fewer GLP-1 Doses Maintain Weight Loss

Doctors have started to personalize GLP-1 dosing with surprising outcomes.

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Previously treated patients with NSCLC respond to anti-CTLA-4 therapy.

Todays Updates

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Previously treated patients with NSCLC respond to anti-CTLA-4 therapy.

Latest News

A recent retrospective analysis assesses the incidence and risk factors for sacral fractures among patients receiving short-course radiation therapy for rectal cancer.

A nationwide Korean cohort study of more than 6.2 million young adults found an association between heavy alcohol use and pancreatic cancer risk before age 50.

Researchers found potential links between gut bacteria and memory loss, with gut-brain connections triggering loss of memory encoding in the hippocampus.

AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant improvement in ⁠how long patients with a common liver cancer lived...

Most gastric cancers found in people diagnosed with H pylori may already be present at diagnosis, and treatment of the infection may not provide short-term protection.

Doctors have started to personalize GLP-1 dosing with surprising outcomes.

News All Time

From Royal Courts to Clinics: How Enemas Evolved

Once considered a universal remedy, enemas are now used selectively for specific clinical indications, such as bowel preparation.

Popular Caraway Oil for Dyspepsia: Benefit or Risk?

Caraway oil is widely used for digestive symptoms; however, strong clinical evidence supports its use in combination with peppermint oil for functional dyspepsia.

Duchenne Gene Therapy Shows Improved Muscle Function in Trial

Regenxbio said on Wednesday that interim data from a early-to-mid stage study of its experimental gene therapy ⁠in patients with Duchenne muscular dystrophy showed continued...

Early Top-Down Therapy Cuts Surgery Risk in Crohn’s

Five-year PROFILE follow-up shows early top-down infliximab-based therapy markedly reduces abdominal surgery and hospitalizations in Crohn’s vs step-up escalation.

Commercial Microbiome Tests: Unreliable Results

Study finds major methodological differences across seven direct-to-consumer stool tests, producing taxonomic profiles as variable as those between individuals — limiting clinical use.

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

AI Beats Conventional Endoscopy in Neoplasm Detection

AI-assisted esophagogastroduodenoscopy is more effective than the conventional procedure in detecting upper GI neoplasms, particularly for lesions measuring ≤ 10 mm.

Global Study Supports Meat-Free Diets for Cancer Prevention

Observational data on more than 1.8 million people did yield surprises when it came to colorectal and esophageal cancers.

Healthy Midlife Diet Tied to Lower Risk of Cognitive Decline

Greater adherence to the DASH diet and other healthy eating patterns — especially in midlife — is linked to lower risk of cognitive decline later in life, three major US studies show.

CDC Vaccine Advisors to Consider COVID-19 Vaccine Injuries, Long COVID

The U.S. CDC's vaccine advisory committee will discuss and may vote on recommendations ⁠for issues including COVID-19 vaccine injuries and long COVID at its scheduled...

Risankizumab Effective in Crohn's, Real-World Data Show

Risankizumab is effective in inducing clinical and endoscopic remission and is generally well tolerated in patients with Crohn's disease, a real-world study shows.

Rifabutin Regimen Matches Bismuth Regimen in H pylori Rescue

Rifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.

Guinea-Bissau Stops Vaccine Study Funded by Trump Administration

Guinea-Bissau's foreign minister has said his government has stopped a study funded by the Trump administration aiming to evaluate side effects of the life-saving hepatitis...

Italian Toddler Too Sick for Second Transplant, Doctors Say

An Italian toddler left clinging to life after receiving a damaged donor heart, is not well enough to undergo a second transplant, ⁠a panel of specialists ruled on Wednesday.

Barrett’s Esophagus Guidance Emphasizes Risk Stratification

Emphasis has shifted to high-quality endoscopy based on patient risk stratification.

Unraveling the Complexities of Concomitant IBD and Hepatobiliary Disease, With Natalia Nedelkopoulou, MD Natalia Nedelkopoulou, MD

Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.

Recommended News For You

Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

Recommended Articles For You

Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025 

Understanding the Importance of Knowing Your MCV Normal Range 

Discovering the Benefits of TNK: A Comprehensive Blog Article  

Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

2.

According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.

3.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

4.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

5.

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

1.

Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy

2.

Case Study: Genomic Medicine in Precision Oncology

3.

Understanding Mean Corpuscular Volume: A Comprehensive Guide 

4.

Cardio-Oncology: Managing Heart Failure in Survivors of Cancer

5.

Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

2.

Navigating the Complexities of Ph Negative ALL - Part XVI

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

5.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot